Halladay Benjamin sold ESPR
March 17, 2026 · Form 4 insider transaction
Halladay Benjamin sold 6,424 shares of Esperion Therapeutics, Inc. Common Stock at $2.71 per share, a transaction worth $17.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
6,424
Price
$2.71
Total value
$17.4K
InsiderHalladay Benjamin
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 18, 2026
Shares owned after713,602
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.